ABSTRACT
Objetivo: Describir las principales características socio-demográficas y epidemiológicas, de las pacientes con tumores de ovarios. Métodos: Estudio descriptivo, transversal, con una población de 133 pacientes que acudieron a la consulta de Ginecología Oncológica, del Servicio Oncológico Hospitalario del IVSS, entre julio de 2016 y julio de 2017,con diagnóstico de tumores de ovarios, donde solo 24cumplieron con los criterios de inclusión. Resultados: Mayor procedencia Estado Miranda con 42%. La raza mestiza 46%.El promedio de edad 48,33 años. Menarquia promedio 12,29años. Sexarquia promedio de 19,14 años. Parejas sexuales entre 1-2, 46%. Antecedentes obstétricos: 2,5 gestaciones. Anticonceptivos orales 21%. Dispositivos intrauterinos en 21%.Hábito tabáquico 29%. Síntomas en el 83% (58% aumento de volumen abdominal) con evolución de 4,05 meses. 63%tumores benignos (cistoadenoma mucinoso con 46%), 33%tumores malignos (adenocarcinoma endometroide con 37%)y 4% tumor borderline (atípicamente proliferativo), el tipo(mucinoso). Según la clasificación FIGO estadio 1C y 3C con38% respectivamente. La lateralidad predominante lado derecho(54%). El promedio del tamaño fue de 17,60 cm. Conclusión: Las características socio-demográficas, epidemiológicas y clínico-patológicas, determinan el manejo adecuado de los tumoresde ovarios, por lo que deben ser investigadas a fondo, y deesta manera, ofrecer el mejor tratamiento individualizado a laspacientes(AU)
Objective: To describe the main socio-demographic and epidemiological characteristics of patients with ovarian tumors. Methods: Descriptive, cross-sectional study, with a population of 133 patients who attended the Oncology Gynecology clinic of the Hospital Oncology Service of the IVSS, between July 2016 and July 2017, with diagnosis of ovarian tumors, where only 24 complied with the inclusion criteria. Results: Of the 133 patients who attended the Oncology Gynecology clinic with a diagnosis of ovarian tumors, only 24 patients met the inclusion criteria. Highest origin Miranda State with 42%. The 46% mixed race. The average age 48.33 years. Average menarche 12.29 years. Average sexarchy of 19.14 years. Sexual couples between 1-2, 46%. Obstetric history: 2.5 pregnancies. Oral contraceptives 21%. Intrauterine devices in 21%. Smoking habit 29%. Symptoms in 83% (58% increase in abdominal volume) with evolution of 4.05 months. 63% benign tumors (mucinous cystadenoma with 46%), 33% malignant tumors (endometroid adenocarcinoma with 37%) and 4% borderline (atypically proliferative), the type (mucinous). According to the FIGO stage 1C and 3C classification with 38% respectively. The predominant laterality on the right side (54%). The average size was 17.60 cm. Conclusion: The socio-demographic, epidemiological and clinical-pathological characteristics determine the proper management of ovarian tumors, so they must be thoroughly investigated, and thus offer the best individualized treatment to patients(AU)
Subject(s)
Humans , Female , Adult , Middle Aged , Ovarian Neoplasms/epidemiology , Contraceptives, Oral , Intrauterine Devices , Ovary , Menarche , Cross-Sectional Studies , Gynecology , NeoplasmsABSTRACT
Objective To evaluate the relationship between long non-coding RNAs (LncRNA) in tumor tissues and clinico-pathological features of hepatocllular carcinoma (HCC).Methods Using hepatocellular carcinoma gene database GSE36376,we conducted a study on eight LncRNAs which are associated with liver diseases and analyzed the correlation between these LncRNAs and HCC clinico-pathological characteristics.We also evaluated the potential effect of LncRNAs on HCC development.Results H19 was overexpressed in non-tumorous tissues of HCC (P ＜ 0.05),while MEG3,HOXA13,KCNQ1OT1 were all upregulated in tumorous tissues (all P ＜ 0.05).HULC level in HCC tumorous tissues was negatively correlated with AJCC staging,BCLC staging and tumor size (all P ＜ 0.05).UCA1 was positively correlated with BCLC staging (r =0.135,P ＜ 0.05).Univariate analysis and multivariate logistic analyses showed that UCA1 was a risk factor of intrahepatic metastasis of HCC (OR =6.054,95％ CI =1.429 ～ 25.642,P ＜ 0.05); in contrast,HULC overexpression in tumorous tissues played a positive role in HCC tumor size (OR=0.805,95％CI=0.678 ～0.956,P＜0.05).Conclusion HULC in tumorous tissues suppressed HCC proliferation,while UCA1 was a risk factor of HCC aggressiveness.
ABSTRACT
Objective To investigate the expression of DNM T1 and PDCD4 in Tongue Squamous cell carcinoma and their signif‐icance to Clinical .Methods The protein expression of DNM T1 and PDCD4 in 40 cases of TSCC tissues and The adjacent no tumor tissues were measured by Elivision Two Step immunohistochemical method(IHC) ,the relationship between DNM T1 ,PDCD4 and clinicopathological parameters were analyzed .Results There was positively over expression of DNM T1 while the expression of PD‐CD4 was at a low lever or lost in TSCC tissues ,the expression of two genes DNM T1 and PDCD4 in the adjacent no tumor tissues were in contrast ;there was a significant negative correlation between DNM T1 and PDCD4 expression in TSCC(r = - 0 .452 ,P<0 .05) .The expression of DNM T1 protein were associated with histopathological differentiation types ,regional lymph node metasta‐sis and TNM staging(P< 0 .05) ,it had nothing to do with age and gender ;the expression of PDCD4 protein were associated with regional lymph node metastasis and TNM staging(P< 0 .05) ,and it had nothing to do with age ,gender ,histopathological differenti‐ation types .Conclusion Implying the abnormal expression of DNM T1 and PDCD4 protein might be closely related to the develop‐ment and progression of TSCC .DNM T1 may be participates in the inactivation of PDCD4 expression ,and led to the development of the cancer at last .
ABSTRACT
BACKGROUND/AIMS: Microsatellite instability (MSI) is associated with mutations in the DNA mismatch repair system and accounts for 10-15% of all cases of sporadic colorectal cancer (CRC). However, the characteristics and role of MSI as a marker for predicting the prognosis and therapeutic effect on CRC remain unclear. METHODS: Between June 2003 and December 2007, 259 patients (males, 159 [61%]; age, 63 [+/-11] years) who underwent surgery for CRC were retrospectively enrolled. The clinicopathologic characteristics of patients with high-frequency MSI (MSI-H) CRC were reviewed and compared to patients with low-frequency MSI or microsatellite stable CRC. The patient characteristics and MSI-related data were recorded for the following variables: gender, age, clinicopathologic findings, chemotherapy response, recurrence, and survival. RESULTS: MSI-H CRC was diagnosed in 30 patients (12%), low-frequency MSI CRC was diagnosed in 10 patients (4%), and microsatellite stable CRC in was diagnosed in 219 patients (84%). The MSI-H group exhibited the following characteristics: large size, right colon location, positive response to chemotherapy, low recurrence, longer survival, less neural invasion, poor differentiation, diffuse lymphoid reaction, and mucin pool formation. However, in the chemotherapy group (n=180), MSI-H was not a marker of longer survival. Based on Cox-regression analysis, stage IV CRC (OR=6.66; 95% CI, 2.24-53.00), MSI-H (OR=0.17; 95% CI, 0.04-0.73), and a positive response to chemotherapy (OR=0.02; 95% CI, 0.01-0.11) were related to mortality. CONCLUSIONS: MSI-H CRC had less neural invasion and diffuse lymphoid reaction. Further studies regarding the relationship between those pathologic findings and survival are needed.